Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Brands

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesisMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 25, 2014
Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in miceRiyaz Mohamed, Punithavathi Ranganathan, Calpurnia Jayakumar, et al.
The Journal of Biological Chemistry|April 7, 2004
Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activityChristoph Freiberg, Nina A Brunner, Guido Schiffer, et al.
Journal of Medicinal Chemistry|September 6, 2002
Novel antibiotics for the treatment of gram-positive bacterial infectionsMichael Brands, Rainer Endermann, Reinhold Gahlmann, et al.
Circulation|August 26, 2009
Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart AssociationRachel K Johnson, Lawrence J Appel, Michael Brands, et al.
American Journal of Physiology. Renal Physiology|February 2, 2006
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cellsAmy K Banes-Berceli, Sean Shaw, Guochuan Ma, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzymeAlexander Kuhl, Niels Svenstrup, Christoph Ladel, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activityDieter Beyer, Hein-Peter Kroll, Rainer Endermann, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2019
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft ModelKatrine Wickstroem, Jenny Karlsson, Christine Ellingsen, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|August 9, 2005
Novel, selective indole-based ECE inhibitors: lead optimization via solid-phase and classical synthesisMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 25, 2014
Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in miceRiyaz Mohamed, Punithavathi Ranganathan, Calpurnia Jayakumar, et al.
The Journal of Biological Chemistry|April 7, 2004
Identification and characterization of the first class of potent bacterial acetyl-CoA carboxylase inhibitors with antibacterial activityChristoph Freiberg, Nina A Brunner, Guido Schiffer, et al.
Journal of Medicinal Chemistry|September 6, 2002
Novel antibiotics for the treatment of gram-positive bacterial infectionsMichael Brands, Rainer Endermann, Reinhold Gahlmann, et al.
Circulation|August 26, 2009
Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart AssociationRachel K Johnson, Lawrence J Appel, Michael Brands, et al.
American Journal of Physiology. Renal Physiology|February 2, 2006
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cellsAmy K Banes-Berceli, Sean Shaw, Guochuan Ma, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzymeAlexander Kuhl, Niels Svenstrup, Christoph Ladel, et al.
Chemmedchem|August 8, 2006
Selective indole-based ECE inhibitors: synthesis and pharmacological evaluationMichael Brands, Jens-Kerim Ergüden, Kentaro Hashimoto, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activityDieter Beyer, Hein-Peter Kroll, Rainer Endermann, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2019
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft ModelKatrine Wickstroem, Jenny Karlsson, Christine Ellingsen, et al.
Pageof 4